Conference Coverage

Site of morphea lesions predicts risk of extracutaneous manifestations


 

REPORTING FROM SPD 2018


Among all patients, the researchers found that left-extremity and extensor-extremity lesions had a stronger association with musculoskeletal involvement (odds ratios of 1.26 and 1.94, respectively). “The reasons for this are unclear,” Dr. Chiu said. “We didn’t assess handedness in our study, but that perhaps could explain it; 90% of the general population is right-hand dominant, so perhaps there’s some sort of protective effect if you’re using an extremity more. Joint contractures showed the greatest discrepancy between left and right extremity. So perhaps if you’re using that one side more, you’re less likely to have a joint contracture.”

When the researchers limited the analysis to head lesions, they observed no significant difference in the lesions between the left and right head (OR, 0.72), but anterior head lesions had a stronger association with neurologic signs or symptoms, compared with posterior head lesions (OR, 2.56), as did superior head lesions, compared with inferior head lesions (OR, 2.23). The association between head lesion location and ophthalmologic involvement was not significant.

“The odds of extracutaneous manifestations vary by site of morphea lesions, with higher odds seen on the left extremity, extensor extremity, the anterior head, and the superior head,” Dr. Chiu concluded. “Further research can be done to perhaps help us decide whether this necessitates difference in management or screening.”

The project was funded by the Pediatric Dermatology Research Alliance and the SPD. Dr. Chiu reported having no relevant financial disclosures.

dbrunk@mdedge.com

Pages

Recommended Reading

Pediatric Dermatology Consult - July 2018
MDedge Dermatology
Ozenoxacin is a novel treatment option for impetigo
MDedge Dermatology
Consider potty seats when you see contact dermatitis on toddler bottoms
MDedge Dermatology
Bullae associated with pediatric human parvovirus B19 infection
MDedge Dermatology
FDA approves topical anticholinergic for primary axillary hyperhidrosis
MDedge Dermatology
Pediatric dermatology admissions: Crunching the numbers
MDedge Dermatology
Sunscreen use in grade schoolers: Wide racial, ethnic disparities seen
MDedge Dermatology
Early BCC seen in teen kidney transplant patient
MDedge Dermatology
New analysis improves understanding of PHACE syndrome
MDedge Dermatology
Bivalent HPV vaccine brings no significant increase in 38 potential adverse outcomes
MDedge Dermatology